Sera Prognostics (NASDAQ:SERA – Get Free Report) and MedTech Acquisition (NASDAQ:MTAC – Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, risk, dividends, analyst recommendations, earnings, institutional ownership and profitability. Valuation & Earnings This table compares Sera […]
Sera Prognostics (NASDAQ:SERA – Get Free Report) and MedTech Acquisition (NASDAQ:MTAC – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, valuation, institutional ownership, earnings, dividends, analyst recommendations and profitability. Analyst Ratings This is a summary of […]
MedTech Acquisition (NASDAQ:MTAC – Get Free Report) and Castle Biosciences (NASDAQ:CSTL – Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, valuation, earnings, analyst recommendations, risk, institutional ownership and dividends. Analyst Ratings This is a summary of […]
MedTech Acquisition Co. (OTCMKTS:MTACU – Free Report)’s share price was down 4.2% during trading on Monday . The company traded as low as $9.51 and last traded at $9.86. Approximately 250 shares were traded during trading, a decline of 46% from the average daily volume of 460 shares. The stock had previously closed at $10.29. […]
MedTech Acquisition Co. (NASDAQ:MTAC – Free Report) was the recipient of a significant growth in short interest in June. As of June 15th, there was short interest totalling 6,400 shares, a growth of 137.0% from the May 31st total of 2,700 shares. Based on an average daily trading volume, of 2,700 shares, the short-interest ratio […]